Contributions of GsCouplingGil

Contributions by GsCouplingGil, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 1,544 edits includes activity predating the current log.

1. 17:49, 16 Jul 2026 (diff | hist) Glucose-dependent insulinotropic polypeptide 8,265 ±0 merge two short sections
2. 09:03, 3 Jun 2026 (diff | hist) Incretin effect 7,358 ±0 add confidence interval
3. 06:32, 26 Apr 2026 (diff | hist) Enteroendocrine L cell 5,083 ±0 rm citation to a supplier's own page
4. 22:11, 23 Jan 2026 (diff | hist) Enteroendocrine L cell 5,083 ±0 m move table to the section it supports
5. 09:05, 8 Jan 2026 (diff | hist) Incretin effect 7,358 ±0 m correct percentage: source reports placebo-adjusted
6. 20:09, 25 Nov 2025 (diff | hist) Enteroendocrine L cell 5,083 ±0 add see also
7. 09:37, 24 Oct 2025 (diff | hist) Glucagon-like peptide-1 12,294 ±0 add table
8. 02:08, 5 Oct 2025 (diff | hist) Zhuhai Kerui Biotechnology 7,779 +308 ce
9. 22:03, 29 Sep 2025 (diff | hist) Enteroendocrine L cell 5,083 ±0 expand §L-cell plasticity and regulation
10. 14:59, 31 Mar 2025 (diff | hist) Glucagon-like peptide-1 10,239 ±0 link to the policy rather than restating it
11. 10:27, 18 Feb 2025 (diff | hist) Glucose-dependent insulinotropic polypeptide 6,686 ±0 lead should summarise the body, not add to it
12. 01:57, 4 Oct 2024 (diff | hist) Glucagon-like peptide-1 7,221 +271 m remove weasel wording
13. 22:57, 20 Sep 2024 (diff | hist) Glucose-dependent insulinotropic polypeptide 5,034 +549 rm citation to a supplier's own page
14. 23:54, 8 Sep 2024 (diff | hist) Enteroendocrine L cell 2,621 ±0 split section
15. 00:16, 10 Aug 2024 (diff | hist) Enteroendocrine L cell 2,224 ±0 m move table to the section it supports
16. 12:37, 4 Aug 2024 (diff | hist) Enteroendocrine L cell 2,224 ±0 consistent en dashes in ranges